Bruce Binkowitz
Corporate Officer/Principal bei ARCUTIS BIOTHERAPEUTICS, INC.
Profil
Bruce Binkowitz is currently the Vice President-Biometrics at Arcutis Biotherapeutics, Inc. Prior to this, he was the Vice President-Biometrics at Shionogi, Inc. He holds a graduate degree from the University of Florida and a doctorate from Rutgers School of Public Health.
Aktive Positionen von Bruce Binkowitz
Unternehmen | Position | Beginn |
---|---|---|
ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 23.08.2021 |
Ehemalige bekannte Positionen von Bruce Binkowitz
Unternehmen | Position | Ende |
---|---|---|
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Corporate Officer/Principal | - |
Ausbildung von Bruce Binkowitz
University of Florida | Graduate Degree |
Rutgers School of Public Health | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Health Technology |